Patent · US Active

Use of phosphorylated heptose compounds

US12036229B2 · kind B2 · utility

0Cited by
0References
3Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 11, 2018
Grant dateJul 16, 2024
Priority date
Expiry dateDec 15, 2039

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Phosphorylated heptose compounds are useful in modulating an immune response in a subject. Also, the compounds are useful as adjuvants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.